These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23954005)

  • 1. Efficacy and safety of bepridil for prevention of ICD shocks in patients with Brugada syndrome and idiopathic ventricular fibrillation.
    Aizawa Y; Yamakawa H; Takatsuki S; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Tanimoto K; Mitamura H; Ogawa S; Fukuda K
    Int J Cardiol; 2013 Oct; 168(5):5083-5. PubMed ID: 23954005
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of bepridil to prevent ventricular fibrillation in severe form of early repolarization syndrome.
    Katsuumi G; Shimizu W; Watanabe H; Noda T; Nogami A; Ohkubo K; Makiyama T; Takehara N; Kawamura Y; Hosaka Y; Sato M; Fukae S; Chinushi M; Oda H; Okabe M; Kimura A; Maemura K; Watanabe I; Kamakura S; Horie M; Aizawa Y; Makita N; Minamino T
    Int J Cardiol; 2014 Mar; 172(2):519-22. PubMed ID: 24491875
    [No Abstract]   [Full Text] [Related]  

  • 4. High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome.
    Sumi S; Maruyama S; Shiga Y; Kodama S; Miyoshi K; Tojou H; Yamanouchi Y; Urata H
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):e53-6. PubMed ID: 20059716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of atrial fibrillation in Brugada syndrome patients with an implantable cardioverter defibrillator to prevent inappropriate shocks resulting from rapid atrial fibrillation.
    Sairaku A; Yoshida Y; Nakano Y; Kihara Y
    Int J Cardiol; 2013 Oct; 168(6):5273-6. PubMed ID: 23988302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrical storm in patients with brugada syndrome is associated with early repolarization.
    Kaneko Y; Horie M; Niwano S; Kusano KF; Takatsuki S; Kurita T; Mitsuhashi T; Nakajima T; Irie T; Hasegawa K; Noda T; Kamakura S; Aizawa Y; Yasuoka R; Torigoe K; Suzuki H; Ohe T; Shimizu A; Fukuda K; Kurabayashi M; Aizawa Y
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1122-8. PubMed ID: 25221333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinidine: a valuable medication joins the list of 'endangered species'.
    Viskin S; Antzelevitch C; Márquez MF; Belhassen B
    Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
    [No Abstract]   [Full Text] [Related]  

  • 8. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Brugada Syndrome: Thirty-Three-Year Experience Using Electrophysiologically Guided Therapy With Class 1A Antiarrhythmic Drugs.
    Belhassen B; Rahkovich M; Michowitz Y; Glick A; Viskin S
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1393-402. PubMed ID: 26354972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phenotypic combination of idiopathic VF and Brugada syndrome.
    Martinek M; Purerfellner H
    Pacing Clin Electrophysiol; 2010 Sep; 33(9):e84-7. PubMed ID: 20230473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
    Shinohara T; Ebata Y; Ayabe R; Fukui A; Okada N; Yufu K; Nakagawa M; Takahashi N
    Heart Rhythm; 2014 Aug; 11(8):1441-5. PubMed ID: 24813378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of low-dose bepridil for prevention of ventricular fibrillation in patients with Brugada syndrome with and without SCN5A mutation.
    Murakami M; Nakamura K; Kusano KF; Morita H; Nakagawa K; Tanaka M; Tada T; Toh N; Nishii N; Nagase S; Hata Y; Kohno K; Miura D; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Oct; 56(4):389-95. PubMed ID: 20625312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Sarkozy A; Boussy T; Kourgiannides G; Chierchia GB; Richter S; De Potter T; Geelen P; Wellens F; Spreeuwenberg MD; Brugada P
    Eur Heart J; 2007 Feb; 28(3):334-44. PubMed ID: 17251258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome.
    Chinushi M; Iijima K; Tagawa M; Komura S; Furushima H; Aizawa Y
    J Electrocardiol; 2009; 42(4):367-73. PubMed ID: 19356768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol.
    Ağaç MT; Erkan H; Korkmaz L
    Arch Cardiovasc Dis; 2014; 107(8-9):476-8. PubMed ID: 23791603
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.